Retractable Technologies (NYSE:RVP) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a report published on Sunday morning. The firm issued a hold rating on the stock.

Retractable Technologies Stock Performance

Shares of RVP opened at $0.73 on Friday. Retractable Technologies has a 1-year low of $0.70 and a 1-year high of $1.34. The company has a market capitalization of $21.77 million, a P/E ratio of -1.19 and a beta of 2.06. The company has a debt-to-equity ratio of 0.01, a current ratio of 9.51 and a quick ratio of 6.54. The firm’s 50 day simple moving average is $0.80 and its 200 day simple moving average is $0.98.

Retractable Technologies (NYSE:RVP) last posted its quarterly earnings data on Wednesday, August 14th. The company reported ($0.48) earnings per share for the quarter. Retractable Technologies had a negative net margin of 46.72% and a negative return on equity of 18.67%. The company had revenue of $6.03 million for the quarter.

Insider Activity

In other Retractable Technologies news, CEO Thomas J. Shaw purchased 71,422 shares of the firm’s stock in a transaction on Friday, September 20th. The shares were purchased at an average cost of $0.82 per share, with a total value of $58,566.04. Following the completion of the purchase, the chief executive officer now owns 14,743,907 shares of the company’s stock, valued at $12,090,003.74. The trade was a 0.00 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In the last three months, insiders have bought 176,179 shares of company stock worth $144,814. 54.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC bought a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies at the end of the most recent quarter. Institutional investors and hedge funds own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.